Obviously part of a huge debate across the country right now, mental illness has been unfairly scapegoated as the chief reason for gun violence in America. In this article doctors point out that, while additional recognition and resources for treating mental illness are welcome, the health epidemic resulting from deaths and injuries inflicted by assault weapons is staggering and cannot be alleviated by “treating mental illness.” Read the article here.
During 2013 to 2016, 8.1 percent of American adults aged 20 years and older had depression in a given two-week period, according to a February data brief published by the U.S. Centers for Disease Control and Prevention’s National Center for Health Statistics. Read more here.
Connecting Patients to the drug that best fits their genetic makeup-a discipline called pharmacogenetics-is gaining in popularity, including amongst those suffering from mental illness. Recent research suggests that 2 in 3 Americans suffering from mental illness are interested in taking a genetic test to determine their best treatment plan. Read more here.
An innovative approach to counteract feelings of stress, anxiety and other negative mental states, this watch-like device allows users to feel gentle vibrations on their wrist when their heart rate increases. Read about it here.
New Research hub will focus on populations suffering from developmental disabilities and/or psychiatric disorders, becoming the first in Canada to do so. Experts say research conducted at the center will help doctors to stop conflating disability and mental illness, in so doing allowing for more effective diagnoses and treatment options. Read about it here.
Encouraging news for the Swedish startup Flow Neuroscience that aims to treat depression with a wearable device that sends weak signals to a patients brain. The head gear works in conjunction with an app and is meant to treat depression without the use of anti-depressants. Read about it here.
Transcranial direct current stimulation is safe, effective, and tolerable as an add-on treatment for patients already receiving pharmacologic therapy for bipolar depression (BD), according to researchers in Brazil. Study results were published in JAMA Psychiatry. Read more here.
New Study seeks to identify the specific strain (out of 14) that serves as a modulator of serotonin receptors. As Julia Castello, a graduate student at CUNY says, “Identifying new targets broadens our understanding about the cause of depression as well as the mechanism of action of antidepressants.” Read more here.
Belief that mental illness is biological has increased among both health experts and the public in recent years. But campaigns to treat it as a disease and remove stigma may be lacking because other factors, such as bad character and upbringing, still are viewed as playing a role, a Baylor University study has found. Read more here.
New Research has found that ‘magic mushrooms’ could hold the key to alleviating symptoms of depression, particularly in those who have not seen benefits in more traditional treatments. Read more here.